Belantamab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Belantamab, covering 2025-08-27 to 2025-08-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Autoimmune Disease [Phase 1]